FOXP1 and nasopharyngeal carcinoma: The development and progression of nasopharyngeal carcinoma (NPC) is associated with Epstein–Barr virus (EBV) infection and sustained inflammation, due to the inhibition of forkhead box P1 (FOXP1) tumor-suppressive activity driven by one of the 44 EBV miRNAs, EBV-miR-BART11.